secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avantor, Inc. (AVTR)
CIK:        0001722482
Form:       8-K
Filed at:   2025-10-03T23:59:59+00:00
Accession:  0001628280-25-043910
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avantor appoints former Life Technologies CEO Gregory Lucier to board of directors
--------------------------------------------------------------------------------

- Elected Gregory Lucier as director effective Oct 3, 2025; term expires at 2026 annual meeting.
- Lucier currently serves as Exec Chairman & CEO of Corza Medical; previously CEO of NuVasive and Life Technologies.
- Standard non-employee director compensation: annual cash retainer $95,000 plus RSU grant valued at $210,000 (prorated).
- Lucier also serves on boards of Maravai LifeSciences and as Chairman of Dentsply Sirona.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1722482/000162828025043910/0001628280-25-043910-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1722482/000162828025043910/avtr-20251001.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-043910

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer